Administrative Director, Division of Therapeutic Development, Intervention, and Evaluation

Site:
The Brigham and Women's Hospital, Inc.

Mass General Brigham relies on a wide range of professionals, including doctors, nurses, business people, tech experts, researchers, and systems analysts to advance our mission. As a not-for-profit, we support patient care, research, teaching, and community service, striving to provide exceptional care. We believe that high-performing teams drive groundbreaking medical discoveries and invite all applicants to join us and experience what it means to be part of Mass General Brigham.

As a not-for-profit organization, Mass General Brigham (MGB) is committed to supporting patient care, research, teaching, and service to the community by leading innovation across our system. Founded by Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH), MGB supports a complete continuum of care, including two academic medical centers, community and specialty hospitals, a managed care organization, a physician network, community health centers, home care, and other health-related entities.

The Department of Medicine (DOM) is the largest academic department at both BWH and MGH - and will likely be the largest in the country when fully integrated - and supports a balanced portfolio of clinical services, biomedical research, and education. The DOM is a Harvard Medical School (HMS)-affiliated academic department with >1,900 faculty members, ~20 combined divisions plus research institutes, >500 trainees in accredited programs, nearly $695 million in annual total direct research expenditures, and annual operating revenue of >$1.15

billion dollars across both the hospital and physician organizations. MGB DOM is seeking a visionary and distinguished leader to serve as the Administrative Director (AD) of the Division of Therapeutic Development, Intervention, and Evaluation. The Division will include multiple Sections, including, but not limited to, the Section of Engineering in Medicine ("EIM") and the Section of Pharmacoepidemiology. EIM serves as a premier hub for biotechnology and nanotechnology, focusing on the development of translatable therapeutic platforms and diagnostic tools that solve complex clinical challenges through engineering principles.

This technical innovation will be bolstered by internationally renowned experts in clinical trials design and execution, and real-world effectiveness of therapeutics will be evaluated by experts in the Section of Pharmacoepidemiology. Moreover, the Division is envisioned as the Department's home for large-scale clinical trials to identify the root causes of chronic disease and to implement evidence-based strategies to preserve health across the lifespan.

The Division is expected to have approximately 70 faculty members and >350 employed staff and trainees (including research fellows and post-doctoral NIH trainees). The AD reports jointly to the DOM AMC Executive Director (ED) of Research and to the Division Chief. The AD is accountable for the overall administrative and strategic leadership, operating results, and cost center financial performance of the Division, and may serve as an institutional leader across both hospitals.

The AD partners closely with leaders within the DOM and its central team, as well as leaders across BWH, MGH, and MGB. The AD will have accountability for managing the resources of the Division to meet the AMC-wide expectations of performance, MGB integration, and optimization. Due to the senior level of this position, the AD may also communicate with, prepare materials for, receive direction from, and provide counsel to the Chair, Executive Vice Chair, or Vice President (VP) of the Department of Medicine, the Senior Vice President for AMC Medical Departmental…